NSE filing, NSE: AEQUS. Summary written from the filing by ALFA Finder's alert engine.
Aequs Ltd: key numbers
- Share price
- ₹212.00
- Market cap
- ₹14,218 Cr
- Revenue (annual)
- ₹1,230 Cr
- Net profit (annual)
- ₹-113.2 Cr
- P/E (TTM)
- -70.4×Sector 52.0×
- Promoter holding
- 59.09%+0.00% QoQ
- FII holding
- 5.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aequs Ltd
All →Aequs Earnings Call Transcript: Key Takeaways
Aerospace's strong 44% growth is being overshadowed by execution delays and inventory write-downs in the consumer business.
- Call
- Guides 400% growth
Aequs Employee Stock Options
Aequs Limited's NRC granted 2,00,000 employee stock options under its ESOP 2025 plan at an exercise price of ₹235.50. The grant is an employee incentive step, with no cash raised by the company.
- Execution
- Options vest over a minimum of 1 year and are exercisable within 3 years of vesting
Aequs Results Update
Aequs Q2 FY27 revenue rose 45% YoY, but EBITDA fell 45% and losses widened. Consumer ramp slowed, while ₹6,500 Mn promoter warrants fund expansion.
Aequs Investor Presentation: Key Takeaways
H1 FY27 revenue ₹8,046 Mn (+50% YoY); EBITDA ₹460 Mn (6% margin); PAT loss ₹(1,054) Mn as Consumer ramp costs hit.
Aequs Q2 FY27 Results: Net Loss of ₹52.4 Cr, Loss Widens
Aequs Ltd reported revenue from operations of ₹409.1 Cr (+45.3% YoY) and a net loss of ₹52.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹52.4 Cr
Aequs Convertible Warrants
Aequs shareholders approved preferential warrants to promoter trust Mellwood at the October 22, 2026 EGM. Votes in favour were 98.68%.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.